David K. Hooper

2.2k total citations · 1 hit paper
51 papers, 1.3k citations indexed

About

David K. Hooper is a scholar working on Transplantation, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David K. Hooper has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Transplantation, 12 papers in Nephrology and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David K. Hooper's work include Renal Transplantation Outcomes and Treatments (26 papers), Adolescent and Pediatric Healthcare (10 papers) and Pharmacological Effects and Toxicity Studies (6 papers). David K. Hooper is often cited by papers focused on Renal Transplantation Outcomes and Treatments (26 papers), Adolescent and Pediatric Healthcare (10 papers) and Pharmacological Effects and Toxicity Studies (6 papers). David K. Hooper collaborates with scholars based in United States, Philippines and United Kingdom. David K. Hooper's co-authors include Peter A. Margolis, Craig M. Froehle, Patrick W. Brady, Heather C. Kaplan, W. Matthew Linam, Baldomero M. Olivera, Pradip K. Bandyopadhyay, Jens Goebel, Craig S. Walker and Reshma Shetty and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and PEDIATRICS.

In The Last Decade

David K. Hooper

48 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Influence of Context on Quality Improvement Success in Health Care: A Systematic Review of the Literature

2010 532 citations Heather C. Kaplan, Patrick W. Brady et al. Milbank Quarterly profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David K. Hooper United States	16	367	330	195	149	138	51	1.3k
Laura Pasea United Kingdom	16	125 0.3×	91 0.3×	91 0.5×	132 0.9×	335 2.4×	31	1.4k
Heather J. Baer United States	31	283 0.8×	268 0.8×	105 0.5×	808 5.4×	290 2.1×	63	3.0k
Jeffrey C. Dunkelberg United States	16	259 0.7×	77 0.2×	92 0.5×	213 1.4×	201 1.5×	25	1.4k
Kamna S. Balhara United States	14	101 0.3×	104 0.3×	154 0.8×	346 2.3×	93 0.7×	47	902
June Fabian South Africa	18	60 0.2×	81 0.2×	73 0.4×	122 0.8×	115 0.8×	91	983
Mukta Baweja United States	8	63 0.2×	75 0.2×	102 0.5×	110 0.7×	106 0.8×	8	956
Leo G. Eisenstein United States	5	240 0.7×	17 0.1×	28 0.1×	249 1.7×	70 0.5×	9	1.1k
Wendy Savage United Kingdom	13	115 0.3×	62 0.2×	115 0.6×	316 2.1×	121 0.9×	49	954
Maura McGuire United States	13	451 1.2×	213 0.6×	5 0.0×	123 0.8×	42 0.3×	44	1.5k
Paul J. M. van der Boog Netherlands	21	177 0.5×	69 0.2×	356 1.8×	295 2.0×	200 1.4×	62	1.2k

Countries citing papers authored by David K. Hooper

Since Specialization

Citations

This map shows the geographic impact of David K. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K. Hooper more than expected).

Fields of papers citing papers by David K. Hooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K. Hooper. The network helps show where David K. Hooper may publish in the future.

Co-authorship network of co-authors of David K. Hooper

This figure shows the co-authorship network connecting the top 25 collaborators of David K. Hooper. A scholar is included among the top collaborators of David K. Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K. Hooper. David K. Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hooper, David K., et al.. (2025). 79 Case review: Withdrawal of IV glucose therapy for refractory hypoglycaemia in a patient with metastatic insulinoma. Poster presentations. A37.3–A38.

George, Roshan, Amy G. Feldman, Angela Lorts, et al.. (2024). Pediatric Learning Health Networks in Solid Organ Transplantation—Engaging all Stakeholders to Achieve Health for Children Who Require Transplantation. Pediatric Transplantation. 28(7). e14862–e14862.

Hooper, David K., et al.. (2023). Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients. Clinical and Translational Science. 16(10). 1768–1778. 2 indexed citations

Varnell, Charles D., Peter A. Margolis, Jens Goebel, & David K. Hooper. (2022). The learning health system for pediatric nephrology: building better systems to improve health. Pediatric Nephrology. 38(1). 35–46. 5 indexed citations

Varnell, Charles D., et al.. (2022). A Cost-effectiveness Analysis of Adherence Promotion Strategies to Improve Rejection Rates in Adolescent Kidney Transplant Recipients. American Journal of Kidney Diseases. 80(3). 330–340. 5 indexed citations

Ryan, Thomas D., David K. Hooper, David S. Cooper, et al.. (2022). Heart-kidney listing is better than isolated heart listing for pediatric heart transplant candidates with significant renal insufficiency. Journal of Thoracic and Cardiovascular Surgery. 164(6). 2019–2031. 5 indexed citations

Hooper, David K., Charles D. Varnell, Adam C. Carle, et al.. (2021). A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study. American Journal of Kidney Diseases. 79(3). 335–346. 15 indexed citations

Slagle, Cara, et al.. (2021). Blood transfusion rates in Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action)—a single-center experience. Pediatric Nephrology. 36(7). 1901–1905. 3 indexed citations

Varnell, Charles D., Samhar Al‐Akash, Craig W. Belsha, et al.. (2020). Incidence of COVID-19 Disease in Pediatric Kidney Transplant Recipients: A Report of the Improving Renal Outcomes Collaborative. Journal of the American Society of Nephrology. 31(10S). 277–277.

10.

Kirby, Cassie, et al.. (2018). Composite Health Outcomes in Pediatric and Young Adult Kidney Transplant Recipients. The Journal of Pediatrics. 204. 196–202. 5 indexed citations

11.

Hooper, David K. & Mark Mitsnefes. (2015). A systems-based approach to managing blood pressure in children following kidney transplantation. Pediatric Nephrology. 31(10). 1593–1604. 5 indexed citations

12.

Nehus, Edward, et al.. (2015). Clinical Practice of Steroid Avoidance in Pediatric Kidney Transplantation. American Journal of Transplantation. 15(8). 2203–2210. 14 indexed citations

13.

Hooper, David K., Adam C. Carle, Sandra Amaral, et al.. (2013). The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatric Nephrology. 28(6). 939–949. 16 indexed citations

14.

Hooper, David K., Tsuyoshi Fukuda, Barbara Logan, et al.. (2012). Risk of Tacrolimus Toxicity in CYP3A5 Nonexpressors Treated With Intravenous Nicardipine After Kidney Transplantation. Transplantation. 93(8). 806–812. 22 indexed citations

15.

Saldaña, Shannon N., David K. Hooper, Tanya E. Froehlich, et al.. (2011). Characteristics of Successful Recruitment in Prospective Pediatric Pharmacogenetic Studies. Clinical Therapeutics. 33(12). 2072–2081. 3 indexed citations

16.

Kaplan, Heather C., Patrick W. Brady, David K. Hooper, et al.. (2010). The Influence of Context on Quality Improvement Success in Health Care: A Systematic Review of the Literature. Milbank Quarterly. 88(4). 500–559. 532 indexed citations breakdown →

17.

Hooper, David K., et al.. (2010). Interaction between tacrolimus and intravenous nicardipine in the treatment of post‐kidney transplant hypertension at pediatric hospitals. Pediatric Transplantation. 15(1). 88–95. 7 indexed citations

18.

Hooper, David K., John A. Hawkins, Thomas Fuller, Tracie Profaizer, & Robert E. Shaddy. (2005). Panel-Reactive Antibodies Late After Allograft Implantation in Children. The Annals of Thoracic Surgery. 79(2). 641–644. 46 indexed citations

19.

Raetz, Elizabeth A., Philip J. Moos, Carol S. Bruggers, et al.. (2003). Identification of genes that are regulated transcriptionally by Myc in childhood tumors. Cancer. 98(4). 841–853. 31 indexed citations

20.

Hooper, David K., Gloria P. Corpuz, Cecilia A. Ramilo, et al.. (2000). The Spasmodic Peptide Defines a New Conotoxin Superfamily. Biochemistry. 39(7). 1583–1588. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact